News Feature


Nature Biotechnology 25, 707 - 709 (2007)
Published online: 2 July 2007 | doi:10.1038/nbt0707-707

Bad medicine

Cormac Sheridan1

  1. Dublin, Ireland


As more high-ticket biologic drugs reach the marketplace, the biotech industry may be increasingly beset by counterfeiters. Do regulators and law enforcement have the tools they need?

Top

Extra navigation

Search PubMed for

naturejobs

natureproducts


ADVERTISEMENT